3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Interventions
pembrolizumab
24
Carboplatin
21
Paclitaxel
20
olaparib
19
Magnetic Resonance Spectroscopy
14
Bevacizumab
14
Cyclophosphamide
12
Specimen Handling
11
Nivolumab
11
Gemcitabine
11
Taxes
10
niraparib
8
Cisplatin
8
Biopsy
8
liposomal doxorubicin
7
fludarabine
7
Surveys and Questionnaires
6
Immunoglobulin G
6
Doxorubicin
6
Disulfides
6
durvalumab
5
palbociclib
4
oregovomab
4
X-Rays
4
Ipilimumab
4
Fulvestrant
4
mirvetuximab soravtansine
3
ipatasertib
3
defactinib
3
cediranib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Ovarian Neoplasms
×
Glutamyl Aminopeptidase
×
Clear all
NCT05415527
2026-01-29
OPTIMOVA
Institut Bergonié
Phase NA
Active not recruiting
25 enrolled